Early experience with delamanid-containing regimens in the treatment of complicated multidrug-resistant tuberculosis in Hong Kong

Eur Respir J. 2018 Jun 14;51(6):1800159. doi: 10.1183/13993003.00159-2018. Print 2018 Jun.

Authors

Affiliations

¹ Tuberculosis and Chest Service, Dept of Health, Hong Kong SAR, China [email protected].
² Tuberculosis and Chest Service, Dept of Health, Hong Kong SAR, China.
³ Tuberculosis and Chest Unit, Grantham Hospital, Hong Kong SAR, China.
⁴ Dept of Respiratory Medicine, Kowloon Hospital, Hong Kong SAR, China.
⁵ Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong SAR, China.

PMID: 29650556
DOI: 10.1183/13993003.00159-2018

No abstract available

Publication types

Letter

MeSH terms

Adult
Antitubercular Agents / therapeutic use*
Female
Hong Kong
Humans
Male
Middle Aged
Nitroimidazoles / therapeutic use*
Oxazoles / therapeutic use*
Treatment Outcome
Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

Antitubercular Agents
Nitroimidazoles
OPC-67683
Oxazoles